Skip to search formSkip to main contentSkip to account menu

LK 903

Known as: LK-903 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Synthetic applications of Baylis-Hillman chemistry: an efficient and solely stereoselective synthesis of (E)-alpha-methylcinnamic acids and potent hypolipidemic agent LK-903 from unmodified Baylis…
An efficient and solely stereoselective synthesis of (E)-alpha-methylcinnamic acids has been accomplished in single pot by… 
1988
1988
Lymphatic absorption of hypolipidemic compound, 1-O-[p-(myristyloxy)-alpha-methylcinnamoyl] glycerol (LK-903).
The intestinal absorption process of 1-O-[p-(myristyloxy)-alpha-methylcinnamoyl] glycerol (LK-903), a new hypolipidemic compound… 
1981
1981
Induction of peroxisomal enzymes in rat liver by the hypolipidemic agent LK-903.
1981
1981
Intraparticulate localization of some peroxisomal enzymes related to fatty acid beta-oxidation.
Male Wistar rats were given a diet containing 0.05% (w/w) LK-903 (alpha-methyl-p-myristyroxycinnamic acid 1-monoglyceride) for 2… 
1978
1978
Hypocholesterolemic activities of LK-903 and clofibrate in miniature pigs, cynomolgus monkeys and beagle dogs.
The hypocholesterolemic activities of LK-903 (α-methyl-p-myristyloxycinnamic acid-1-monoglyceride) and clofibrate were examined… 
1978
1978
Antilipolytic effect of p-myristyloxy-alpha-methylcinnamic acid (LK-903 acid) as a mechanism of the hypolipidemic action of its alpha-monoglyceride (LK-903).
1978
1978
Hypolipidemic effect of alpha-mono-p-myristyloxy-alpha'-methylcinnamoyl glycerol (LK-903) in rats.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)